1.
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
by Ettehad, Dena, MSc
The Lancet (British edition), 2015, Vol.387 (10022), p.957-967

2.
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis
by Xie, Xinfang, MD
The Lancet (British edition), 2016, Vol.387 (10017), p.435-443

3.
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review
by Chow, Clara K, Prof
The Lancet (British edition), 2017, Vol.389 (10073), p.1035-1042

4.
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
by Fox, Caroline S, MD
The Lancet (British edition), 2012, Vol.380 (9854), p.1662-1673

5.
Injury in elite New Zealand cricketers 2002–2008: descriptive epidemiology
by Frost, Warren Leonard
British journal of sports medicine, 2014-06, Vol.48 (12), p.1002-1007

6.
Higher mortality in patients with right hemispheric intracerebral haemorrhage: INTERACT1 and 2
by Sato, Shoichiro
Journal of neurology, neurosurgery and psychiatry, 2015-12, Vol.86 (12), p.1319-1323

7.
Systematic Risk and the Muni Puzzle
by Chalmers, John M.R
National tax journal, 2006-12-01, Vol.59 (4), p.833-848

8.
An Economic Evaluation of a Perindopril-Based Blood Pressure Lowering Regimen for Patients Who Have Suffered a Cerebrovascular Event
by Tavakoli, Manouchehr
The European journal of health economics, 2009-02-01, Vol.10 (1), p.111-119

9.
How to increase value and reduce waste when research priorities are set
by Chalmers, Iain, DSc
The Lancet (British edition), 2014, Vol.383 (9912), p.156-165

10.
Biomedical research: increasing value, reducing waste
by Macleod, Malcolm R
The Lancet (British edition), 2014, Vol.383 (9912), p.101-104

11.
Larger effect sizes in nonrandomized studies are associated with higher rates of EMA licensing approval
by Djulbegovic, Benjamin
Journal of clinical epidemiology, 2018-06, Vol.98, p.24-32

12.
The generalizability of bronchiectasis randomized controlled trials: A multicentre cohort study
by Chalmers, James D
Respiratory medicine, 2016, Vol.112, p.51-58

13.
Prevalence, incidence, primary care burden and medical treatment of angina in Scotland: age, sex and socioeconomic disparities: a population-based study
by Murphy, N F
Heart (British Cardiac Society), 2006-08, Vol.92 (8), p.1047-1054

14.
National survey of the prevalence, incidence, primary care burden, and treatment of heart failure in Scotland
by Murphy, N F
Heart (British Cardiac Society), 2004-10, Vol.90 (10), p.1129-1136

15.
Pulmonary arterial pulse pressure and mortality in pulmonary arterial hypertension
by Blyth, Kevin G
Respiratory medicine, 2007, Vol.101 (12), p.2495-2501

16.
Progress of The Lancet Palestinian Health Alliance
by Watt, Graham
The Lancet (British edition), 2014, Vol.383 (9914), p.e5-e6

17.
Achieving compliance with pool fencing legislation in New Zealand: a survey of regulatory authorities
by Morrison, Luke
Injury prevention, 1999-06, Vol.5 (2), p.114-118

18.
New Zealand's Injury Prevention Research Unit: helping shape injury prevention policy and practice
by Chalmers, David J
Injury prevention, 1999-03, Vol.5 (1), p.72-75
